Giant Papillary Conjunctivitis Overview

Save information for later
Sign Up

Learn About Giant Papillary Conjunctivitis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Giant Papillary Conjunctivitis Local Doctors?
Elite in Giant Papillary Conjunctivitis
Elite in Giant Papillary Conjunctivitis
Padova, IT 

Andrea Leonardi practices in Padova, Italy. Ms. Leonardi is rated as an Elite expert by MediFind in the treatment of Giant Papillary Conjunctivitis. Her top areas of expertise are Giant Papillary Conjunctivitis, Allergic Conjunctivitis, Vernal Keratoconjunctivitis, and Conjunctivitis (Pink Eye).

Elite in Giant Papillary Conjunctivitis
Elite in Giant Papillary Conjunctivitis
Urayasu, JP 

Nobuyuki Ebihara practices in Urayasu, Japan. Mr. Ebihara is rated as an Elite expert by MediFind in the treatment of Giant Papillary Conjunctivitis. His top areas of expertise are Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Allergic Conjunctivitis, Vitrectomy, and Trabeculectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Giant Papillary Conjunctivitis
Elite in Giant Papillary Conjunctivitis
Paris, FR 

Dominique Gignac-Bremond practices in Paris, France. Gignac-Bremond is rated as an Elite expert by MediFind in the treatment of Giant Papillary Conjunctivitis. Their top areas of expertise are Giant Papillary Conjunctivitis, Aniridia, Vernal Keratoconjunctivitis, Vitrectomy, and Cataract Removal.

What are the latest Giant Papillary Conjunctivitis Clinical Trials?
Contribution of Local Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Production Upon Nasal Allergen Contact - an Explorative Pilot Study

Summary: IgE-associated allergies are consistently on the rise forming an enormous wellbeing concern and affecting about 25% of the population around the world, with main prevalence in developed nations. Birch pollen is one important allergen driving allergic conjunctivitis and rhinitis. The characteristics and location IgE producing cells in the nose and their contribution to the subsequent increase in al...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Single-Center, Randomized, Double-masked, Vehicle-controlled Phase 2 Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model

Summary: In this prospective, Phase 2, randomized, double-masked, vehicle controlled study, approximately 66 eligible subjects will be randomized 1:1 to receive either TL-925 or placebo as topical ophthalmic eye drops administered bilaterally. The study comprises of a screening and treatment period using the conjunctival allergen challenge model to evaluate TL-925 for the treatment of allergic conjunctivit...